FDA issues draft guidance on site changes; Supplier of execution drugs said to be in India;

> Compounder refuses FDA request that it stop making products. Story

> The FDA has issued draft guidance called Manufacturing Site Change Supplements: Content and Submission. Post (PDF)

> BuzzFeed claims they have located a man in India named Chris Harris who has been supplying U.S. states with execution drugs. Story

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.